Clinical Trial Update: Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 non-inferiority trial compares reduced-target IMRT to full-target IMRT after chemotherapy in immunotherapy-treated metastatic nasopharyngeal carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Ming-Yuan Chen | Conditions: Nasopharyngeal Carcinoma (NPC) | Phase 3 | Status: RECRUITING